NASDAQ:PIRS - Pieris Pharmaceuticals, Inc.
$3.10
 $-0.02
-0.64%
4:00PM EDT
2019-03-25
Pieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Its Anticalins proteins are a class of low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins typically found in blood plasma and other bodily fluids. It is focused on developing three drug candidates, which include PRS-080, PRS-060 and PRS-300 series. Its PRS-080 is an Anticalin drug candidate targeting hepcidin. The Company's second Anticalin drug candidate, PRS-060, binds to the IL-4 receptor alpha-chain (IL-4RA), thereby inhibiting the actions of IL-4 and IL-13, two cytokines known to be mediators in the inflammatory cascade that causes asthma and other inflammatory diseases. PRS-343 is an Anticalin-based drug candidate. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  PIRS     avg for
industry  
  avg for
sector  
42 stocks weight:  13. 82   0. 00   0. 00  
42 stocks rank:  3. 28 K 1. 47 K 813. 28  
# analyst opinions:  2. 00   14. 60   13. 76  
mean recommendation:  1. 60   2. 08   1. 94  

quick ratio:  3. 51   5. 02   1. 92  
current ratio:  3. 62   5. 37   2. 41  

target price low:  3. 18   86. 57   112. 35  
target price avg:  5. 00   113. 88   131. 59  
target price high:  7. 50   139. 18   151. 05  
1-yr high:  6. 88   117. 54   131. 86  
last close:  3. 10   98. 55   115. 48  
50-day avg:  2. 96   99. 18   115. 72  
200-day avg:  4. 23   97. 41   113. 92  
1-yr low:  2. 46   75. 41   92. 07  
volume:  341. 28 K 2. 47 M 4. 15 M
50-day avg volume:  319. 99 K 2. 85 M 4. 53 M
200-day avg volume:  470. 49 K 2. 93 M 4. 35 M

1-day return:  -0. 64 % 0. 22 % -0. 06 %
this week return:  -0. 64 % 0. 22 % -0. 06 %
12-wk return:  12. 32 % 10. 73 % 9. 15 %
52-wk return:  -56. 22 % 9. 95 % 19. 39 %

enterprise value (EV):  35. 98 M 51. 84 B 103. 78 B
market cap:  167. 87 M 45. 80 B 92. 73 B
EBITDA:  -11. 19 M 4. 55 B 6. 74 B
enterprise multiple (EV/EBITDA):  -3. 21   6. 01   13. 57  
enterprise/revenue (EV/R):  0. 85   57. 99   13. 57  
total revenue:  42. 34 M 10. 84 B 37. 97 B
total debt:  0. 00   12. 38 B 16. 39 B
net income (common):  -7. 58 M 2. 28 B 3. 51 B

shares outstanding:  54. 15 M 579. 54 M 1. 21 B
shares:  54. 04 M 579. 89 M 1. 18 B
shares short:  2. 24 M 9. 60 M 17. 98 M
shares short prior month:  2. 34 M 10. 48 M 11. 44 M
short ratio:  5. 47   5. 48   3. 47  
short % of float:  4. 16 % 6. 10 % 2. 53 %
total cash/share:  2. 54   11. 14   8. 46  
total cash:  137. 30 M 6. 79 B 5. 92 B
free cash flow:  -6. 64 M 3. 65 B 4. 03 B
operating cash flow:  3. 30 M 4. 24 B 5. 35 B

book value:  0. 93   13. 42   27. 58  
price/book:  3. 34   2. 67   -3. 06  
gross profits:  25. 27 M 8. 18 B 37. 21 B
operating margins:  -27. 62 % -691. 69 % -99. 65 %
EBITDA margins:  -26. 43 % 12. 76 % 20. 68 %
profit margins:  -17. 91 % 9. 80 % 9. 36 %
gross margins:  100. 00 % 42. 57 % 53. 92 %

1-yr max volatility:  14. 12 % --- ---
1-yr mean volatility:  -0. 26 % 0. 05 % 0. 08 %

1-yr EPS:  -0. 15   2. 98   3. 81  
forward EPS:  -1. 11   4. 58   6. 86  
P/E:  -20. 81   17. 33   25. 71  
forward P/E:  -2. 81   -44. 22   11. 00  
PE/G:  -0. 18   -2. 22   0. 51  
growth:  112. 50 % 94. 22 % 28. 45 %
earnings high:  -0. 18   1. 15   1. 57  
earnings avg:  -0. 19   0. 90   1. 44  
earnings low:  -0. 19   0. 61   1. 32  
revenue high:  6. 69 M 2. 74 B 10. 73 B
revenue avg:  6. 25 M 2. 65 B 10. 55 B
revenue low:  5. 80 M 2. 54 B 10. 35 B
return on assets:  -5. 83 % -1. 39 % 5. 03 %
return on equity:  -27. 66 % -7. 64 % 6. 55 %
revenue growth:  112. 50 % 56. 26 % 16. 88 %
revenue/share:  0. 83   14. 17   56. 58  

beta (1yr vs S&P500):  1. 20   1. 25   0. 95  
sharpe (1yr):  -1. 08   0. 55   1. 18  

held % insiders:  0. 23 % 6. 44 % 3. 73 %
held % institutions:  72. 89 % 79. 27 % 68. 99 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-03-25 : PIRS
.    + 1.612 =         1.612 :: INITIAL WEIGHT
.   + 48.649 =        50.261 :: inverse volume-to-price addition
.   + 32.845 =        83.106 :: spline projection addition
.   - 23.304 =        59.802 :: add/subtract for performance
.    x 4.788 =       286.357 :: 13 weeks' performance factor
.    x 0.648 =       185.472 :: one-year gains+dividend factor
.    x 1.437 =       266.528 :: industry recommendation factor
.    x 2.358 =       628.484 :: symbol recommendation factor
.    x 1.015 =       637.696 :: EV/R factor
.    x 0.999 =       637.324 :: return on assets factor
.    x 0.997 =       635.561 :: return on equity factor
.      x 2.2 =      1398.334 :: revenue growth factor
.    x 2.673 =      3738.443 :: current ratio factor
.    x 1.182 =      4419.865 :: quick ratio factor
.    x 1.088 =      4806.927 :: short ratio factor
.    x 2.033 =       9774.43 :: price-to-book factor
.    x 1.072 =     10475.666 :: 5-day avg > 50-day avg
.     x 1.31 =     13718.729 :: P/E weight
.    x 1.525 =      20919.83 :: PE/G factor
.    x 1.446 =     30254.938 :: beta factor
.    x 0.851 =     25758.074 :: sharpe factor
.    x 1.161 =     29908.692 :: target low factor
.    x 1.261 =     37713.678 :: target mean factor
.    x 1.119 =      42206.76 :: target high factor
.    x 1.107 =     46736.012 :: industry 12-weeks return
.    x 0.932 =     43567.544 :: "drift" penalty 1 days ago
.    x 0.993 =     43273.844 :: overall "drift" factor
.    x 0.859 =     37164.593 :: largest single-day jump factor
.    x 0.071 =      2639.531 :: low price factor
.    x 0.999 =      2637.772 :: factor hist industry gain for week 12
.   cubeRoot =        13.817 :: reduced to standardize
.                     13.817 :: FINAL WEIGHT for NASDAQ:PIRS


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org